Skip to content

Research at St Andrews

ALEXANDRA/IMpassion030: A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early-stage triple-negative breast cancer.

Research output: Contribution to journalAbstractpeer-review

Author(s)

Heather L. McArthur, Michail Ignatiadis, Sebastian Guillaume, Andrew Bailey, Jorge Luis Martinez, Mariana Brandao, Otto Metzger, Catherine Lai, Debora Fumagalli, Fergus Daly, Aicha Bouhlel, Valeria Karusinova, Christie Freeman, Giuseppe Viale, Vanessa Honvault, Carter Dufrane, Anh Nguyen Duc, Martine J. Piccart, Eric S. Winer, Richard D. Gelber

School/Research organisations

Details

Original languageEnglish
Number of pages2
JournalJournal of Clinical Oncology
Volume37
Issue number15
DOIs
Publication statusPublished - 20 May 2019
EventAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, Israel
Duration: 31 May 20194 Jun 2019

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Lucitanib for the treatment of HR+/HER2- metastatic breast cancer: results from the multicohort phase II FINESSE study

    Hui, R., Pearson, A., Cortes, J., Campbell, C., Poirot, C., Azim, H. A., Fumagalli, D., Lambertini, M., Daly, F., Arahmani, A., Perez-Garcia, J., Aftimos, P., Bedard, P. L., Xuereb, L., Scheepers, E. D., Vicente, M., Goulioti, T., Loibl, S., Loi, S., Pierrat, M-J. & 3 others, Turner, N. C., Andre, F. & Curigliano, G., 15 Jan 2020, In: Clinical Cancer Research. 26, 2, p. 354-363 10 p.

    Research output: Contribution to journalArticlepeer-review

  2. Relief of neuropathic pain through epidermal growth factor receptor inhibition: a randomized proof-of-concept trial

    Kersten, C., Cameron, M. G., Bailey, A. G., Fallon, M. T., Laird, B. J., Paterson, V., Mitchell, R., Fleetwood-Walker, S. M., Daly, F. & Mjaland, S., Dec 2019, In: Pain medicine. 20, 12, p. 2495-2505 11 p.

    Research output: Contribution to journalArticlepeer-review

  3. The impact of early lapatinib-induced rash on disease-free and overall survival in patients treated within the ALTTO phase Ill randomized trial

    Azim, H. A., Sonnenblick, A., Agbor-Tarh, D., Bradbury, I., Daly, F., Huang, Y., Dueck, A. C., Pritchard, K., Wolff, A. C., Jackisch, C., Lang, I., Untch, M., Smith, I., Boyle, F., Xu, B., Gomez, H., Perez, E., Piccart, M. & de Azambuja, E., 15 Feb 2016, In: Cancer Research. 76, 2 p.

    Research output: Contribution to journalAbstractpeer-review

  4. Antiviral treatment for Bell's palsy (idiopathic facial paralysis)

    Gagyor, I., Madhok, V. B., Daly, F., Somasundara, D., Sullivan, M., Gammie, F. & Sullivan, F., 2015, In: Cochrane Database of Systematic Reviews. 7, 56 p., 001869.

    Research output: Contribution to journalReview articlepeer-review

Related by journal

  1. Use of a high-sensitivity anti-Mullerian hormone (AMH) assay to determine ovarian function after chemotherapy for early breast cancer

    Clatot, F., Kelsey, T., Lambertini, M., Olympos, N., Duhamel, O., Perdix, A. & Anderson, R., 30 May 2021, In: Journal of Clinical Oncology. 39, 15_suppl

    Research output: Contribution to journalAbstractpeer-review

  2. Effect of psychological intervention on fear of cancer recurrence: a systematic review and meta-analysis

    Tauber, N. M., O'Toole, M. S., Dinkel, A., Galica, J., Humphris, G., Lebel, S., Maheu, C., Ozakinci, G., Prins, J., Sharpe, L., Smith, A. B., Thewes, B., Simard, S. & Zachariae, R., 18 Sep 2019, (E-pub ahead of print) In: Journal of Clinical Oncology. 37, 18 p.

    Research output: Contribution to journalReview articlepeer-review

  3. New model for estimating glomerular filtration rate in patients with cancer

    Janowitz, T., Williams, E. H., Marshall, A., Ainsworth, N., Thomas, P. B., Sammut, S. J., Shepherd, S., White, J., Mark, P. B., Lynch, A. G., Jodrell, D. I., Tavaré, S. & Earl, H., Aug 2017, In: Journal of Clinical Oncology. 35, 24, p. 2798-2805 10 p.

    Research output: Contribution to journalArticlepeer-review

  4. The effect of sunitinib on biomarkers and tumor heterogeneity in metastatic clear cell renal cancer.

    Stewart, G., Laird, A., O'Mahony, F., Eory, L., Lubbock, A., Nanda, J., O'Donnell, M., Mackay, A., Mullen, P., McNeill, A., Riddick, A., Aitchison, M., Berney, D., Bex, A., Overton, I., Harrison, D. J. & Powles, T., 1 Feb 2014, In: Journal of Clinical Oncology. 32, 4, 1 p.

    Research output: Contribution to journalAbstractpeer-review

ID: 270380780

Top